Healthcare provider profile · identity verified

Aruna Khan, MD

Family Practice · JACKSONVILLE, FL · NPI 1407200918

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	563	176
Atorvastatin Calcium	Atorvastatin Calcium	548	191
Amlodipine Besylate	Amlodipine Besylate	537	183
Losartan Potassium	Losartan Potassium	384	135
Rosuvastatin Calcium	Rosuvastatin Calcium	341	125
Lisinopril	Lisinopril	331	115
Hydrochlorothiazide	Hydrochlorothiazide	253	85
Pantoprazole Sodium	Pantoprazole Sodium	238	93
Omeprazole	Omeprazole	226	90
Metformin Hcl	Metformin Hcl	197	83
Metoprolol Succinate	Metoprolol Succinate	181	63
Pravastatin Sodium	Pravastatin Sodium	174	53
Simvastatin	Simvastatin	164	60
Metoprolol Tartrate	Metoprolol Tartrate	138	49
Sertraline Hcl	Sertraline Hcl	137	44
Albuterol Sulfate Hfa	Albuterol Sulfate	134	56
Trazodone Hcl	Trazodone Hcl	121	50
Furosemide	Furosemide	112	49
Escitalopram Oxalate	Escitalopram Oxalate	111	32
Buspirone Hcl	Buspirone Hcl	110	41
Zolpidem Tartrate	Zolpidem Tartrate	110	29
Atenolol	Atenolol	102	33
Gabapentin	Gabapentin	100	39
Ezetimibe	Ezetimibe	93	41
Allopurinol	Allopurinol	90	29
Alprazolam	Alprazolam	85	48
Montelukast Sodium	Montelukast Sodium	82	29
Citalopram Hbr	Citalopram Hydrobromide	81	26
Potassium Chloride	Potassium Chloride	77	30
Tamsulosin Hcl	Tamsulosin Hcl	77	28
Eliquis	Apixaban	76	30
Glipizide	Glipizide	71	27
Metformin Hcl Er	Metformin Hcl	66	24
Synthroid	Levothyroxine Sodium	66	21
Carvedilol	Carvedilol	61	21
Fluticasone Propionate	Fluticasone Propionate	60	27
Donepezil Hcl	Donepezil Hcl	58	13
Clopidogrel	Clopidogrel Bisulfate	53	21
Meloxicam	Meloxicam	52	26
Doxazosin Mesylate	Doxazosin Mesylate	51	15
Benazepril Hcl	Benazepril Hcl	49	14
Fluoxetine Hcl	Fluoxetine Hcl	48	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	18
Famotidine	Famotidine	45	18
Glipizide Er	Glipizide	42	14
Clonidine Hcl	Clonidine Hcl	41	15
Duloxetine Hcl	Duloxetine Hcl	41	16
Valsartan	Valsartan	41	17
Clonazepam	Clonazepam	39	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	13
Glimepiride	Glimepiride	37	16
Lorazepam	Lorazepam	37	15
Oxybutynin Chloride Er	Oxybutynin Chloride	37	11
Spironolactone	Spironolactone	37	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	36	14
Mounjaro	Tirzepatide	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Januvia	Sitagliptin Phosphate	32	18
Ozempic	Semaglutide	32	13
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Fenofibrate	Fenofibrate	28	11
Paroxetine Hcl	Paroxetine Hcl	28	12
Gemfibrozil	Gemfibrozil	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Mirtazapine	Mirtazapine	23	12
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	11
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	21
Lovastatin	Lovastatin	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	15
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Azithromycin	Azithromycin	18	16
Candesartan Cilexetil	Candesartan Cilexetil	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Finasteride	Finasteride	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Terconazole	Terconazole	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Edarbyclor	Azilsartan Med/Chlorthalidone	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Baclofen	Baclofen	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Estradiol	Estradiol	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Lorazepam Intensol	Lorazepam	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error